11，Mafson EJ． Conner JM． Kordower JH. Nerve growth factor in Alzheimer＇s Disease defective retrograde transport to nucleus bas-alis. Neuroreport．1995；61063～1066
22，Nabeshima T. Nerve growth factor and preparation of animal model for Alzheimer-type senile dementia. Yakugaku Zassi．1995115（7）:499～512
33，Kapl D Rudolpli KA.New pharmacologic aspects in the neurol-ogic profile of propentofylline. Tierarztl prax Ausg K KlientiereHeimtiere．199826（5）:317～321
44，Charles V． Mufson EJ． Friden PM et al. Atrophy of cholinergicbasal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate. BrainRes．1996728193～203
55，Hu L． Cote SL, Cuello AC. Differential modulation of the choliergic phenotype of the nucleus basalis magnocellularis neurons byapplying NGF at the cell body or cortical terminal fields.Exp Ne-urol．1997143（1）:162～171
66，Fischer W． Sirevaag A． Wiegand SJ et al. Reversal of spatitalmemory impairments in aged rats by nerve growth factor and neurotrophin-3 and 4/5 but not brain-derived neurotrophic factor.Proc Natl Acad Sci USA．1994918607～8011
77，Lapohak PA． Hefti F. Effects of recombinant human NGF onpresynaptic cholinergic function in rat hippocampal slices foll-owing partial septohippocampal lesions Measuresm of [3H] ac
88，Burgos I． Cuello AC. Liberini P et al. NGF-mediated synapticsprouting in the cerebral cortex of lesioned primate brain.BrainRes．1995692154～160
99，Eriksdotter． JM． Nordberg A． Amberla K et al. Intracerebroven-tricular infusion of nerve growth factor in three patients with Alzheimer＇s disease. Dement Geriatr cogn Disord．19989（5）:246～257
1010，Tuszynski MH． Roberts J． Senut MC et al.Gene therapy in theadult primate brain intraparenchymal grafts of cells geneticallymodified to produce nerve growth factor prevent cholinergic ne-uronal degeneration. Gene Ther．19963（4）:305～314
